Tapewire

Nasdaq · USD

MDGL

MADRIGAL PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
3441
SEC CIK
0001157601
Parsed reports
271

Last 12 months

Inside the activity.

0 purchase rows · 202 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025036
Dec 2025034
Jan 2026066
Feb 202600
Mar 2026017
Apr 202600
May 2026013
Jun 202601
Jul 2026010
Aug 202601
Sep 2026024
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 08, 2024 Filed Apr 11, 2024 00:50 UTC SaleCommon Stock 3,730 $244.12 $910,566.48
Disclosure

SEC source: 0000950170-24-043502 · ownership.xml · nonDerivative · entry 3

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 206,834

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.43 to $244.42, inclusive.

Read SEC document
April 08, 2024 Filed Apr 11, 2024 00:50 UTC SaleCommon Stock 1,441 $242.95 $350,094.26
Disclosure

SEC source: 0000950170-24-043502 · ownership.xml · nonDerivative · entry 2

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 210,564

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.39 to $243.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.

Read SEC document
April 08, 2024 Filed Apr 11, 2024 00:50 UTC Exercise / conversionCommon Stock 26,270 $9.45 $248,251.50
Disclosure

SEC source: 0000950170-24-043502 · ownership.xml · nonDerivative · entry 1

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 212,005

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 05, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
Exercise / conversionStock Option (Right to Buy) · Derivative 27,506 $0.00 Strike: $9.45 $0.00
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · derivative · entry 26

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 79,240

Underlying: Common Stock · 27,506 shares

Expires 2026-07-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F20 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable.

Read SEC document
April 05, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
SaleCommon Stock 5,278 $245.53 $1,295,924.23
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 22

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 458,999

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F18 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.03 to $245.88, inclusive.

Read SEC document
April 05, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
SaleCommon Stock 2,079 $244.45 $508,213.42
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 21

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 464,277

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.03 to $245.02, inclusive.

Read SEC document
April 05, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
SaleCommon Stock 8,989 $243.33 $2,187,287.98
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 20

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 466,356

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.00 to $243.95, inclusive.

Read SEC document
April 05, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
SaleCommon Stock 8,817 $242.61 $2,139,068.56
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 19

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 475,345

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.00 to $242.99, inclusive.

Read SEC document
April 05, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
SaleCommon Stock 700 $241.14 $168,798.91
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 18

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 484,162

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.67 to $241.64, inclusive.

Read SEC document
April 05, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
SaleCommon Stock 1,643 $240.11 $394,496.79
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 17

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 484,862

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $239.57 to $240.52, inclusive.

Read SEC document
April 05, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
Exercise / conversionCommon Stock 27,506 $9.45 $259,931.70
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 16

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 486,505

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 05, 2024 Filed Apr 6, 2024 00:50 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 27,613 $0.00 Strike: $9.45 $0.00
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · derivative · entry 27

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 232,526

Underlying: Common Stock · 27,613 shares

Expires 2026-07-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F22 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable.

Read SEC document
April 05, 2024 Filed Apr 6, 2024 00:50 UTC SaleCommon Stock 444 $245.92 $109,189.41
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 23

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 185,735

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F20 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.86 to $246.02, inclusive.

Read SEC document
April 05, 2024 Filed Apr 6, 2024 00:50 UTC SaleCommon Stock 5,228 $245.35 $1,282,668.89
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 22

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 186,179

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F19 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.83 to $245.81, inclusive.

Read SEC document
April 05, 2024 Filed Apr 6, 2024 00:50 UTC SaleCommon Stock 3,966 $244.22 $968,587.62
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 21

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 191,407

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F18 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.80 to $244.79, inclusive.

Read SEC document
April 05, 2024 Filed Apr 6, 2024 00:50 UTC SaleCommon Stock 9,264 $243.20 $2,253,015.92
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 20

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 195,373

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.80 to $243.79, inclusive.

Read SEC document
April 05, 2024 Filed Apr 6, 2024 00:50 UTC SaleCommon Stock 6,679 $242.42 $1,619,097.80
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 19

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 204,637

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $241.795 to $242.78, inclusive.

Read SEC document
April 05, 2024 Filed Apr 6, 2024 00:50 UTC SaleCommon Stock 612 $241.15 $147,582.45
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 18

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 211,316

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.67 to $241.64, inclusive.

Read SEC document
April 05, 2024 Filed Apr 6, 2024 00:50 UTC SaleCommon Stock 1,420 $240.10 $340,939.02
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 17

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 211,928

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $239.67 to $240.64, inclusive.

Read SEC document
April 05, 2024 Filed Apr 6, 2024 00:50 UTC Exercise / conversionCommon Stock 27,613 $9.45 $260,942.85
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 16

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 213,348

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 04, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
Exercise / conversionStock Option (Right to Buy) · Derivative 18,537 $0.00 Strike: $9.45 $0.00
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · derivative · entry 25

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,746

Underlying: Common Stock · 18,537 shares

Expires 2026-07-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F20 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable.

Read SEC document
April 04, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
SaleCommon Stock 100 $248.23 $24,823.00
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 15

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 458,999

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

Read SEC document
April 04, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
SaleCommon Stock 711 $247.23 $175,778.25
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 14

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 459,099

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.78 to $247.68, inclusive.

Read SEC document
April 04, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
SaleCommon Stock 1,653 $246.01 $406,658.33
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 13

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 459,810

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.52 to $246.50, inclusive.

Read SEC document
April 04, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
SaleCommon Stock 2,734 $245.06 $670,005.80
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 12

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 461,463

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.49 to $245.47, inclusive.

Read SEC document
April 04, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
SaleCommon Stock 435 $244.01 $106,142.87
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 11

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 464,197

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.40 to $244.39, inclusive.

Read SEC document
April 04, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
SaleCommon Stock 3,085 $242.71 $748,764.67
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 10

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 464,632

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.38 to $243.35, inclusive.

Read SEC document
April 04, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
SaleCommon Stock 5,619 $241.85 $1,358,970.88
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 9

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 467,717

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $241.37 to $242.36, inclusive.

Read SEC document
April 04, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
SaleCommon Stock 4,200 $240.88 $1,011,678.78
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 8

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 473,336

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.33 to $241.29, inclusive.

Read SEC document
April 04, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
Exercise / conversionCommon Stock 18,537 $9.45 $175,174.65
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 7

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 477,536

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 04, 2024 Filed Apr 6, 2024 00:50 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 18,710 $0.00 Strike: $9.45 $0.00
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · derivative · entry 26

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 260,139

Underlying: Common Stock · 18,710 shares

Expires 2026-07-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F22 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable.

Read SEC document
April 04, 2024 Filed Apr 6, 2024 00:50 UTC SaleCommon Stock 200 $248.43 $49,685.00
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 15

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 185,735

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.41 to $248.44, inclusive.

Read SEC document
April 04, 2024 Filed Apr 6, 2024 00:50 UTC SaleCommon Stock 737 $247.14 $182,141.07
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 14

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 185,935

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.80 to $247.54, inclusive.

Read SEC document
April 04, 2024 Filed Apr 6, 2024 00:50 UTC SaleCommon Stock 1,558 $246.13 $383,470.85
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 13

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 186,672

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.70 to $246.65, inclusive.

Read SEC document
April 04, 2024 Filed Apr 6, 2024 00:50 UTC SaleCommon Stock 2,549 $245.14 $624,857.02
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 12

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 188,230

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.65 to $245.61, inclusive.

Read SEC document
April 04, 2024 Filed Apr 6, 2024 00:50 UTC SaleCommon Stock 627 $244.31 $153,184.75
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 11

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 190,779

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.65 to $244.63, inclusive.

Read SEC document
April 04, 2024 Filed Apr 6, 2024 00:50 UTC SaleCommon Stock 1,467 $243.00 $356,481.73
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 10

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 191,406

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.60 to $243.55, inclusive.

Read SEC document
April 04, 2024 Filed Apr 6, 2024 00:50 UTC SaleCommon Stock 5,299 $242.25 $1,283,678.51
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 9

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 192,873

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $241.59 to $242.57, inclusive.

Read SEC document
April 04, 2024 Filed Apr 6, 2024 00:50 UTC SaleCommon Stock 6,273 $241.07 $1,512,222.07
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 8

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 198,172

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.52 to $241.46, inclusive.

Read SEC document
April 04, 2024 Filed Apr 6, 2024 00:50 UTC Exercise / conversionCommon Stock 18,710 $9.45 $176,809.50
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 7

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 204,445

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 03, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
Exercise / conversionStock Option (Right to Buy) · Derivative 27,845 $0.00 Strike: $9.45 $0.00
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · derivative · entry 24

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,283

Underlying: Common Stock · 27,845 shares

Expires 2026-07-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F20 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable.

Read SEC document
April 03, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
SaleCommon Stock 2,089 $246.32 $514,572.72
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 6

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 458,999

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.12 to $246.70, inclusive.

Read SEC document
April 03, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
SaleCommon Stock 18,917 $245.34 $4,641,013.55
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 5

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 461,088

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.11 to $246.10, inclusive.

Read SEC document
April 03, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
SaleCommon Stock 4,070 $244.68 $995,853.71
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 4

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 480,005

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.11 to $245.10, inclusive.

Read SEC document
April 03, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
SaleCommon Stock 2,634 $243.68 $641,866.03
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 3

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 484,075

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.11 to $244.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.

Read SEC document
April 03, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
SaleCommon Stock 135 $242.00 $32,670.00
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 2

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 486,709

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

Read SEC document
April 03, 2024 Filed Apr 6, 2024 00:50 UTC
Taub RebeccaDirector · Pres., R&D, and CMO
Exercise / conversionCommon Stock 27,845 $9.45 $263,135.25
Disclosure

SEC source: 0000899243-24-000266 · doc4.xml · nonDerivative · entry 1

Taub Rebecca · CIK 0001423898 · Director · Pres., R&D, and CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 486,844

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 03, 2024 Filed Apr 6, 2024 00:50 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 27,407 $0.00 Strike: $9.45 $0.00
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · derivative · entry 25

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 278,849

Underlying: Common Stock · 27,407 shares

Expires 2026-07-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F22 · derivative.exercise_date: The shares underlying this stock option are fully vested and exercisable.

Read SEC document
April 03, 2024 Filed Apr 6, 2024 00:50 UTC SaleCommon Stock 1,821 $246.31 $448,529.96
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 6

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 185,735

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.09 to $246.57, inclusive.

Read SEC document
April 03, 2024 Filed Apr 6, 2024 00:50 UTC SaleCommon Stock 18,806 $245.34 $4,613,822.67
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 5

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 187,556

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.04 to $246.01, inclusive.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.